Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Buchfuhrer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Evidence-Based Medicine|November 18, 2010
Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadinessMark J Buchfuhrer
Sleep Medicine|July 20, 2007
Restless legs syndrome (RLS) with expansion of symptoms to the faceMark J Buchfuhrer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2012
Strategies for the treatment of restless legs syndromeMark J Buchfuhrer
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 29, 2014
Sensory stimuli and the restless legs syndromeFred Burbank, Mark J Buchfuhrer
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 1, 2023
Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptomsJonathan D Charlesworth, Bahman Adlou, Haramandeep Singh, et al.
BMC Neurology|November 22, 2023
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trialMark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, et al.
Annals of Medicine|April 16, 2015
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbilRichard K Bogan, Daniel O Lee, Mark J Buchfuhrer, et al.
Mayo Clinic Proceedings|July 5, 2021
The Management of Restless Legs Syndrome: An Updated AlgorithmMichael H Silber, Mark J Buchfuhrer, Christopher J Earley, et al.
Mayo Clinic Proceedings|January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Mayo Clinic Proceedings|July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Evidence-Based Medicine|November 18, 2010
Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadinessMark J Buchfuhrer
Sleep Medicine|July 20, 2007
Restless legs syndrome (RLS) with expansion of symptoms to the faceMark J Buchfuhrer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2012
Strategies for the treatment of restless legs syndromeMark J Buchfuhrer
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 29, 2014
Sensory stimuli and the restless legs syndromeFred Burbank, Mark J Buchfuhrer
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 1, 2023
Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptomsJonathan D Charlesworth, Bahman Adlou, Haramandeep Singh, et al.
BMC Neurology|November 22, 2023
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trialMark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, et al.
Annals of Medicine|April 16, 2015
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbilRichard K Bogan, Daniel O Lee, Mark J Buchfuhrer, et al.
Mayo Clinic Proceedings|July 5, 2021
The Management of Restless Legs Syndrome: An Updated AlgorithmMichael H Silber, Mark J Buchfuhrer, Christopher J Earley, et al.
Mayo Clinic Proceedings|January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Mayo Clinic Proceedings|July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs SyndromeMichael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Pageof 2